Back to News
investment

3 Once-in-a-Decade Buying Opportunities

newsfeedback@fool.com (Adria Cimino)
Loading...
6 min read
0 likes
⚡ Quantum Brief
A February 2026 market dip created rare buying opportunities in three dominant tech and biotech leaders after recent S&P 500 declines driven by economic uncertainty and AI disruption fears. Nvidia, the AI chip leader with 700% three-year growth, trades at 23x forward earnings despite record revenue and 70%+ gross margins, positioning it for renewed growth with annual chip updates. Moderna’s stock plunged 70% post-pandemic but rebounded 50% in January 2026, buoyed by a pipeline of cancer and rare-disease mRNA vaccines entering late-stage trials amid regulatory setbacks. Amazon’s AWS cloud division, a hidden profit engine, now generates $142B annual revenue run rate, monetizing AI-driven infrastructure expansions despite investor concerns over capital spending. All three stocks—Nvidia, Moderna, and Amazon—are trading at historic discounts relative to long-term growth potential, offering what analysts call once-in-a-decade entry points for patient investors.
AI Audio Summary
0:00 / 0:00
Click to play
generated-image (61).png
Quantum News · Media Library

By Adria Cimino – Feb 18, 2026 at 6:10PM ESTKey PointsThese three stocks have slipped, but their long-term prospects remain bright.These companies are leaders in their fields. We’re bullish on these 10 stocks ›NASDAQ: NVDANvidiaMarket Cap$4.5TToday's Changeangle-down(1.74%) $3.21Current Price$188.19Price as of February 18, 2026 at 3:58 PM ETBargain-hunters should give these stocks a close look.The S&P 500 delivered strong returns for investors over the past three years as they piled into growth stocks in a number of fields, from technology to biotech and consumer goods. And they took a particular interest in players involved in artificial intelligence (AI), seeing this area as the next big thing. This bet has been a successful one for many, as certain AI companies have already generated fantastic revenue growth and stock performance. But, in recent weeks, the stock market has faced a variety of challenges. Investors have worried about economic factors -- such as the pace of interest rate cuts -- as well as the possibility that AI tools, as they accomplish new tasks, may hurt demand for the products and services of certain companies. These and other headwinds have weighed on the S&P 500, driving it to declines over the past two weeks. But, for the long-term investor, there's a silver lining in this cloud. The declines have left us with the following once-in-a-decade buying opportunities... Image source: Getty Images. 1. Nvidia Nvidia (NVDA +1.74%) has driven stock market gains in recent years thanks to its leadership in the AI market. The stock has soared more than 700% over the past three years as investors scrambled to get in on what they saw as the key player in the AI revolution. Nvidia designs the world's most powerful AI chips, and as a result, major tech companies have turned to this leader for their AI projects. ExpandNASDAQ: NVDANvidiaToday's Change(1.74%) $3.21Current Price$188.19Key Data PointsMarket Cap$4.5TDay's Range$186.77 - $190.3652wk Range$86.62 - $212.19Volume5.3MAvg Vol180MGross Margin70.05%Dividend Yield0.02% This has helped the chip designer generate double-digit revenue growth in recent quarters, with revenue reaching record levels. And this has been done at high levels of profitability -- gross margin has steadily exceeded 70%. Nvidia has already established itself as an AI giant, and the company's commitment to innovation should keep it in this valuable position. The tech player has pledged to update its chips annually, and the next release is set for later this year. This should spark a new wave of growth at that time and into 2027. Considering this track record and likelihood of future strength, Nvidia looks dirt cheap at 23x forward earnings estimates. 2. Moderna Moderna (MRNA +6.10%) has had its share of difficult times over the past few years. The coronavirus vaccine giant once was a highflier, but when demand for that product dropped, many investors lost interest in the biotech company. Meanwhile, in more recent times, Moderna has faced a challenging vaccine policy environment. The government last year cut funding for mRNA vaccine research, and just recently, U.S. regulators said they wouldn't review the company's flu vaccine application. So, why should you buy the biotech at this point? Moderna has a full pipeline of promising potential products -- from an investigational cancer vaccine involved in phase 3 trials to earlier-stage candidates for rare diseases. Even a few successes here in the future could transform Moderna in a very positive way. ExpandNASDAQ: MRNAModernaToday's Change(6.10%) $2.68Current Price$46.61Key Data PointsMarket Cap$17BDay's Range$45.66 - $47.6852wk Range$22.28 - $55.20Volume528KAvg Vol12MGross Margin55.35% Moderna stock started this year off with momentum, gaining nearly 50% in January after losing more than 70% over the past three years. This stock may still face some tough moments in the quarters ahead, but the headwinds we've seen so far don't change the long-term prospects. That's why now, while the stock still is in a recovery stage, is a great time to buy. 3. Amazon Amazon (AMZN +1.90%), like Nvidia, has been an early winner of the AI boom. You may link Amazon more with e-commerce than anything else -- but the company's cloud business, Amazon Web Services (AWS), actually drives overall profit. And this unit has become an AI leader, offering a wide range of AI products and services to its customers. ExpandNASDAQ: AMZNAmazonToday's Change(1.90%) $3.83Current Price$204.98Key Data PointsMarket Cap$2.2TDay's Range$201.53 - $206.8652wk Range$161.38 - $258.60Volume2.8MAvg Vol47MGross Margin50.29% This leadership has helped AWS reach an annual revenue run rate of $142 billion, and the company recently said that as it opens up new capacity to customers, it immediately monetizes it. Even though investors have worried about Amazon's significant capital investments to support the infrastructure buildout, this message should relieve those concerns. Amazon and its peers continue to see soaring demand -- so this investment may be the ticket to revenue growth now and moving forward. All of this means that today, as Amazon trades for 25x forward earnings estimates, the stock looks like an amazing deal -- and this could even be a once-in-decade buying opportunity. Read NextFeb 18, 2026 •By Manali Pradhan, CFAPrediction: These 3 AI Stocks Will Have Tremendous Momentum in 2026Feb 18, 2026 •By Justin PopeGot $5,000? 5 Tech Stocks to Buy and Hold for the Long TermFeb 18, 2026 •By Marc Guberti3 No-Brainer Growth Stocks to Buy With $500 Right NowFeb 18, 2026 •By Keith SpeightsPrediction: Nvidia Stock Will Drop After Feb. 25Feb 17, 2026 •By Lee SamahaHow Nvidia and AI are Driving Demand for Silver HigherFeb 17, 2026 •By Keithen DruryPrediction: These Will Be the Best-Performing AI Stocks in 2026About the AuthorAdria Cimino is a contributing Motley Fool stock market analyst covering healthcare, technology, and consumer goods sectors. Prior to The Motley Fool, Adria covered the European stock market and U.S. stocks pre-market trading for Bloomberg News, Bloomberg TV, and Bloomberg Radio for more than a decade. Earlier in her career, she wrote about biotech, medtech, and technology companies in Boston for Mass High Tech, an American City Business Journals publication. She holds a bachelor’s degree in mass communications from the University of South Florida.TMFAdriaCiminoX@adria_in_parisStocks MentionedNvidiaNASDAQ: NVDA$188.19 (+1.74%) $+3.21AmazonNASDAQ: AMZN$204.98 (+1.90%) $+3.83ModernaNASDAQ: MRNA$46.61 (+6.10%) $+2.68*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.